US Patent 7067515 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease
Patent 7067515 was granted and assigned to Pfizer on June, 2006 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7067515 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
